ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45 | -34.8% | 195 | 0.0% | 0.00% | – |
| Q1 2023 | $69 | +9.5% | 195 | 0.0% | 0.00% | – |
| Q4 2022 | $63 | – | 195 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 195 | -69.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 642 | -15.6% | 0.00% | – |
| Q1 2022 | $1,000 | -92.9% | 761 | -80.7% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | -39.1% | 3,948 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | +15.0% | 3,948 | +5.1% | 0.00% | 0.0% |
| Q1 2021 | $20,000 | +566.7% | 3,755 | +1.0% | 0.00% | – |
| Q3 2020 | $3,000 | -57.1% | 3,717 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | -22.2% | 3,717 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $9,000 | +350.0% | 3,717 | +310.7% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 905 | -4.5% | 0.00% | – |
| Q3 2019 | $2,000 | – | 948 | +9380.0% | 0.00% | – |
| Q4 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |